
Toyobo Co., Ltd.
3101.TJPXBasic MaterialsChemicals - Specialty
Latest quote
¥1,640
+¥11.00 · +0.68%
3101.T company overview
Regular session · JST · Market data may be delayed.
Company profile
Company websiteEstablished in 1882 and headquartered in Osaka, Japan, Toyobo Co., Ltd. is a global enterprise delivering a diverse range of products. The company specializes in the manufacturing of films and advanced polymers, industrial components, healthcare solutions, and various textile goods. Its films and functional polymers division produces industrial PET films for applications such as liquid crystal displays and optics, in addition to synthetic papers. It also supplies a variety of packaging films, including PET, polyolefin, and nylon options for food products, along with heat-shrink PET films. The company's portfolio of functional polymers features engineering plastics, industrial adhesives, specialized coatings, photosensitive printing plates, acrylate polymers, and electronic materials. This segment further encompasses rubber and coat processing, as well as pharmaceutical intermediates. Within its industrial materials segment, Toyobo develops functional fibers for airbag construction, polyethylene fibers, and PBO fibers. It also creates functional filters for automotive and indoor environments, materials for anti-pollution solvent adsorption, and fiber components utilized in vehicle parts. In the healthcare sector, the company provides a comprehensive selection of bio-products, which includes enzymes for diagnostic purposes, diagnostic systems, and research reagents. Its contributions also extend to artificial kidney hollow fibers, anti-clotting substances, and seawater desalination modules. For textiles, Toyobo supplies functional fabrics suitable for sports clothing, undergarments, and uniforms, alongside synthetic filaments. The company markets apparel under its Munsingwear brand, acrylic fibers under Exlan, and acrylate fibers under the eks brand, while also engaging in general textile product commerce. Beyond these offerings, Toyobo serves as a contract manufacturer for injectable pharmaceuticals.
- Industry
- Chemicals - Specialty
- Sector
- Basic Materials
- Headquarters
- JP
- CEO
- Ikuo Takeuchi
- Listed since
- Jan 4, 2000
- Employees
- 9,398
Market position
Day range
Current ¥1,640
52-week range
Current ¥1,640
- Open
- ¥1,635
- Previous close
- ¥1,629
- Volume
- 306K
- 0.39× average
- Average volume
- 783.31K
- Average daily volume
- Market cap
- 144.72B JPY
- Beta
- 0.75
- Market reference 1
- 50-day average
- ¥1,668.06
- -1.68% below average
- 200-day average
- ¥1,482.33
- +10.64% above average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 346.09B JPY
- P/E (TTM)
- 11.44×
- P/B (TTM)
- 0.68×
- P/S (TTM)
- 0.34×
- EV / EBITDA
- 6.59×
- Earnings yield
- 9.62%
- Free cash flow yield
- 12.15%
- Dividend yield
- 2.43%
Profitability & efficiency
- Gross margin
- 25.72%
- Operating margin
- 6.87%
- Net margin
- 2.95%
- Return on equity
- 5.24%
- Return on assets
- 1.78%
- Return on invested capital
- 3.73%
Financial health
- Debt / equity
- 1.2×
- Current ratio
- 1.72×
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (JPY) | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 421.56B JPY | 422.03B JPY | 414.27B JPY | 399.92B JPY | 375.72B JPY |
| Cost of goods sold | 313.41B JPY | 324.98B JPY | 326.27B JPY | 314.81B JPY | 279.51B JPY |
| Gross profit | 108.15B JPY | 97.06B JPY | 88B JPY | 85.11B JPY | 96.21B JPY |
| Research and development | — | 14.36B JPY | 15.39B JPY | 14.11B JPY | 13.79B JPY |
| Selling, general, and administrative | 80.25B JPY | 66.04B JPY | 63.61B JPY | 60.93B JPY | 53.99B JPY |
| Operating expenses | 80.25B JPY | 80.4B JPY | 79B JPY | 75.04B JPY | 67.78B JPY |
| Interest expense | 2.92B JPY | 2.18B JPY | 1.36B JPY | 1.33B JPY | 1.21B JPY |
| Depreciation and amortization | 24.63B JPY | 22.7B JPY | 19.81B JPY | 19.05B JPY | 20.08B JPY |
| Operating income | 27.91B JPY | 16.65B JPY | 9B JPY | 10.06B JPY | 28.43B JPY |
| Net income | 11.17B JPY | 2B JPY | 2.46B JPY | −655M JPY | 12.87B JPY |
Company facts updated Aug 24, 2026.
Earnings
- Latest EPS result
- 34.82
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
Corporate actions
Annual dividends per share
Cash distributions grouped by calendar year; partial years are marked.
¥40.00
2025 complete year0.0% since 2021
2026 partial: ¥40.00
¥40.00
2,021
¥40.00
2,022
¥40.00
2,023
¥40.00
2,024
¥40.00
2,025
¥40.00
2,026*
* Partial calendar year in the available dividend history.
Corporate action history
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
DividendUpcoming | Mar 30, 2027 | ¥40.00Annual | Mar 31, 2027 | Mar 30, 2027 |
Dividend | Mar 30, 2026 | ¥40.00Annual | Mar 31, 2026 | Jun 25, 2026 |
Dividend | Mar 28, 2025 | ¥40.00Annual | Mar 31, 2025 | Jun 26, 2025 |
Dividend | Mar 28, 2024 | ¥40.00Annual | Mar 31, 2024 | Jun 26, 2024 |
Dividend | Mar 30, 2023 | ¥40.00Annual | Mar 31, 2023 | Jun 29, 2023 |
Dividend | Mar 30, 2022 | ¥40.00Annual | Mar 31, 2022 | Jun 27, 2022 |
Ex-dividend Mar 30, 2027
¥40.00
Annual
Record Mar 31, 2027 · Payment Mar 30, 2027
Ex-dividend Mar 30, 2026
¥40.00
Annual
Record Mar 31, 2026 · Payment Jun 25, 2026
Ex-dividend Mar 28, 2025
¥40.00
Annual
Record Mar 31, 2025 · Payment Jun 26, 2025
Ex-dividend Mar 28, 2024
¥40.00
Annual
Record Mar 31, 2024 · Payment Jun 26, 2024
Ex-dividend Mar 30, 2023
¥40.00
Annual
Record Mar 31, 2023 · Payment Jun 29, 2023
Ex-dividend Mar 30, 2022
¥40.00
Annual
Record Mar 31, 2022 · Payment Jun 27, 2022
3101.T peers
ETFs holding 3101.T
Funds reporting this stock among their holdings, ordered by reported position size.
iShares Core TOPIX ETF1475.T359.52M0.01%2.89T JPY0.05%¥419+0.24%
Avantis International Small Cap Value ETFAVDV22.4M0.11%20.24B USD0.36%$111.95+1.06%
Vanguard Total International Stock ETFVXUS11.75M0.00%646.2B USD0.05%$87.71+0.78%
Dimensional - International Small Cap Value ETFDISV7.81M0.15%5.23B USD0.42%$44.49+0.86%
Vanguard FTSE Developed Markets ETFVEA7.61M0.00%315B USD0.03%$73.42+0.80%
iShares Core MSCI EAFE ETFIEFA7.31M0.00%195.14B USD0.07%$100.85+0.86%
Vanguard FTSE All-World ex-US Small-Cap ETFVSS3.1M0.02%13.6B USD0.06%$160.06+0.43%
Dimensional - International Small Cap ETFDFIS2.92M0.05%5.91B USD0.39%$37.545+0.71%
iShares Core TOPIX ETF1475.T- Market value
- 359.52M
- Weight
- 0.01%
- AUM
- 2.89T JPY
- Expense ratio
- 0.05%
- Price / 1D
- ¥419+0.24%
Avantis International Small Cap Value ETFAVDV- Market value
- 22.4M
- Weight
- 0.11%
- AUM
- 20.24B USD
- Expense ratio
- 0.36%
- Price / 1D
- $111.95+1.06%
Vanguard Total International Stock ETFVXUS- Market value
- 11.75M
- Weight
- 0.00%
- AUM
- 646.2B USD
- Expense ratio
- 0.05%
- Price / 1D
- $87.71+0.78%
Dimensional - International Small Cap Value ETFDISV- Market value
- 7.81M
- Weight
- 0.15%
- AUM
- 5.23B USD
- Expense ratio
- 0.42%
- Price / 1D
- $44.49+0.86%
Vanguard FTSE Developed Markets ETFVEA- Market value
- 7.61M
- Weight
- 0.00%
- AUM
- 315B USD
- Expense ratio
- 0.03%
- Price / 1D
- $73.42+0.80%
iShares Core MSCI EAFE ETFIEFA- Market value
- 7.31M
- Weight
- 0.00%
- AUM
- 195.14B USD
- Expense ratio
- 0.07%
- Price / 1D
- $100.85+0.86%
Vanguard FTSE All-World ex-US Small-Cap ETFVSS- Market value
- 3.1M
- Weight
- 0.02%
- AUM
- 13.6B USD
- Expense ratio
- 0.06%
- Price / 1D
- $160.06+0.43%
Dimensional - International Small Cap ETFDFIS- Market value
- 2.92M
- Weight
- 0.05%
- AUM
- 5.91B USD
- Expense ratio
- 0.39%
- Price / 1D
- $37.545+0.71%
Continue in GoAI
Research 3101.Tresearch.disclaimer





